NCT07459634
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07459634
Title A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jazz Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Valkyrie Clinical Trials, Inc. RECRUITING Los Angeles California 90067 United States Details
Cancer Specialists of North Florida RECRUITING Jacksonville Florida 32256 United States Details
Emory University RECRUITING Atlanta Georgia 30322 United States Details
Carolina Blood and Cancer Care RECRUITING Rock Hill South Carolina 29732 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field